Multiple Assemblies exist for SMTL entry 9ay9
Co-crystal structure of human PRMT9 in complex with MRK-990 inhibitor; X-RAY DIFFRACTION 2.22 Å

	SMTL ID 9ay9.1 Ligands 7-[5-S-(4-{[(2-tert-butylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Polypeptides Protein arginine N-methyltransferase 9 Oligo-state monomer
	SMTL ID 9ay9.2 Ligands 7-[5-S-(4-{[(2-tert-butylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Polypeptides Protein arginine N-methyltransferase 9 Oligo-state monomer
	SMTL ID 9ay9.3 Ligands 7-[5-S-(4-{[(2-tert-butylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; UNKNOWN ATOM OR ION Polypeptides Protein arginine N-methyltransferase 9 Oligo-state monomer
	SMTL ID 9ay9.4 Ligands 7-[5-S-(4-{[(2-tert-butylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; UNKNOWN ATOM OR ION Polypeptides Protein arginine N-methyltransferase 9 Oligo-state monomer